S&P Rates S. Pasadena Unif Sch Dist,CA G.O. Bnds AA- Jan 98

  • ID: 2041144
  • January 1998
  • Standard & Poors
1 of 3

NY -- Standard & Poor's CreditWire 1/29/98 -- Standard & Poor's today assigned its double-`A'-minus rating to South Pasadena Unified School District, Calif.'s $10 million G.O. bonds (Election of 1995) series 1998B dated Feb. 1, 1998 due Nov. 1, 2022. The school district's outstanding debt has been affirmed at double-`A'-minus. South Pasadena Unified School District's rating reflects: -- The affluent residential community's access to the Los Angeles metropolitan area's broad employment base, -- Maintenance of strong general fund balances, and -- A moderate debt burden combined with a manageable capital improvement plan. The residential district is coterminous with the city of South Pasadena which has a stable population base of approximately 25,000. Its location, just six miles northeast of downtown...

Companies mentioned in this report are: South Pasadena Unif Sch Dist
Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

South Pasadena Unif Sch Dist

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown





Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.